vs
Side-by-side financial comparison of DT Cloud Star Acquisition Corp (DTSQ) and Vir Biotechnology, Inc. (VIR). Click either name above to swap in a different company.
DT Cloud Star Acquisition Corp is the larger business by last-quarter revenue ($452.4K vs $240.0K, roughly 1.9× Vir Biotechnology, Inc.). DT Cloud Star Acquisition Corp runs the higher net margin — 63.7% vs -67975.4%, a 68039.1% gap on every dollar of revenue.
DT Cloud Star Acquisition Corp is a special purpose acquisition company dedicated to pursuing business combinations with high-growth enterprises operating in cloud technology, enterprise software and digital services sectors, primarily targeting innovative players across the Asia-Pacific region.
Vir Biotechnology, Inc. is a clinical-stage immunology company focused on developing innovative therapies and vaccines to address serious infectious diseases including COVID-19, hepatitis B, HIV, and influenza. It operates primarily in the global biopharmaceutical market, collaborating with leading industry partners to advance its pipeline of targeted immune-based solutions for patient populations worldwide.
DTSQ vs VIR — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $452.4K | $240.0K |
| Net Profit | $288.0K | $-163.1M |
| Gross Margin | — | — |
| Operating Margin | -36.4% | -72267.9% |
| Net Margin | 63.7% | -67975.4% |
| Revenue YoY | — | -89.9% |
| Net Profit YoY | — | 23.7% |
| EPS (diluted) | — | $-1.17 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $452.4K | — | ||
| Q3 25 | $751.5K | $240.0K | ||
| Q2 25 | $742.2K | $1.2M | ||
| Q1 25 | $737.7K | $3.0M | ||
| Q4 24 | — | $12.4M | ||
| Q3 24 | — | $2.4M | ||
| Q2 24 | — | $3.1M | ||
| Q1 24 | — | $56.4M |
| Q4 25 | $288.0K | — | ||
| Q3 25 | $583.0K | $-163.1M | ||
| Q2 25 | $631.5K | $-111.0M | ||
| Q1 25 | $630.3K | $-121.0M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $-213.7M | ||
| Q2 24 | — | $-138.4M | ||
| Q1 24 | — | $-65.3M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 99.1% | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 97.9% | ||
| Q2 24 | — | 98.3% | ||
| Q1 24 | — | 99.9% |
| Q4 25 | -36.4% | — | ||
| Q3 25 | -22.5% | -72267.9% | ||
| Q2 25 | -15.2% | -9754.3% | ||
| Q1 25 | -15.0% | -4602.5% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -9718.7% | ||
| Q2 24 | — | -5158.7% | ||
| Q1 24 | — | -142.0% |
| Q4 25 | 63.7% | — | ||
| Q3 25 | 77.6% | -67975.4% | ||
| Q2 25 | 85.1% | -9139.9% | ||
| Q1 25 | 85.4% | -3989.6% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -8979.7% | ||
| Q2 24 | — | -4500.1% | ||
| Q1 24 | — | -115.8% |
| Q4 25 | — | — | ||
| Q3 25 | — | $-1.17 | ||
| Q2 25 | — | $-0.80 | ||
| Q1 25 | — | $-0.88 | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $-1.56 | ||
| Q2 24 | — | $-1.02 | ||
| Q1 24 | — | $-0.48 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $461 | $497.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-1.1M | $796.1M |
| Total Assets | $18.0M | $1.0B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $461 | — | ||
| Q3 25 | $20.1K | $497.8M | ||
| Q2 25 | $126.1K | $598.7M | ||
| Q1 25 | $271.5K | $790.9M | ||
| Q4 24 | — | $901.0M | ||
| Q3 24 | — | $909.0M | ||
| Q2 24 | — | $1.1B | ||
| Q1 24 | — | $1.1B |
| Q4 25 | $-1.1M | — | ||
| Q3 25 | $-736.8K | $796.1M | ||
| Q2 25 | $-568.4K | $947.5M | ||
| Q1 25 | $-457.7K | $1.0B | ||
| Q4 24 | — | $1.2B | ||
| Q3 24 | — | $1.2B | ||
| Q2 24 | — | $1.4B | ||
| Q1 24 | — | $1.5B |
| Q4 25 | $18.0M | — | ||
| Q3 25 | $72.7M | $1.0B | ||
| Q2 25 | $72.1M | $1.2B | ||
| Q1 25 | $71.6M | $1.3B | ||
| Q4 24 | — | $1.4B | ||
| Q3 24 | — | $1.5B | ||
| Q2 24 | — | $1.7B | ||
| Q1 24 | — | $1.8B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-411.0K | $-167.6M |
| Free Cash FlowOCF − Capex | — | $-167.9M |
| FCF MarginFCF / Revenue | — | -69952.9% |
| Capex IntensityCapex / Revenue | — | 132.1% |
| Cash ConversionOCF / Net Profit | -1.43× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-824.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-411.0K | — | ||
| Q3 25 | $-105.9K | $-167.6M | ||
| Q2 25 | $-145.5K | $-120.2M | ||
| Q1 25 | $-139.9K | $-78.1M | ||
| Q4 24 | — | $-446.4M | ||
| Q3 24 | — | $-171.5M | ||
| Q2 24 | — | $-77.8M | ||
| Q1 24 | — | $-109.4M |
| Q4 25 | — | — | ||
| Q3 25 | — | $-167.9M | ||
| Q2 25 | — | $-122.8M | ||
| Q1 25 | — | $-79.7M | ||
| Q4 24 | — | $-453.7M | ||
| Q3 24 | — | $-174.2M | ||
| Q2 24 | — | $-78.5M | ||
| Q1 24 | — | $-111.3M |
| Q4 25 | — | — | ||
| Q3 25 | — | -69952.9% | ||
| Q2 25 | — | -10111.8% | ||
| Q1 25 | — | -2630.1% | ||
| Q4 24 | — | -3666.2% | ||
| Q3 24 | — | -7321.3% | ||
| Q2 24 | — | -2553.3% | ||
| Q1 24 | — | -197.4% |
| Q4 25 | — | — | ||
| Q3 25 | — | 132.1% | ||
| Q2 25 | — | 209.1% | ||
| Q1 25 | — | 53.7% | ||
| Q4 24 | — | 59.0% | ||
| Q3 24 | — | 116.3% | ||
| Q2 24 | — | 21.7% | ||
| Q1 24 | — | 3.3% |
| Q4 25 | -1.43× | — | ||
| Q3 25 | -0.18× | — | ||
| Q2 25 | -0.23× | — | ||
| Q1 25 | -0.22× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
